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Abstract 
In computational biology and other sciences, researchers are frequently faced with a choice 
between several computational methods for performing data analyses. Benchmarking studies 
aim to rigorously compare the performance of different methods using well-characterized 
benchmark datasets, to determine the strengths of each method or to provide recommendations 
regarding suitable choices of methods for an analysis. However, benchmarking studies must be 
carefully designed and implemented to provide accurate, unbiased, and informative results. 
Here, we summarize key practical guidelines and recommendations for performing high-quality 
benchmarking analyses, based on our experiences in computational biology. 
 
  
1 
Introduction 
Many fields of computational research are characterized by a growing number of available 
methods for data analysis. For example, at the time of writing, almost 400 methods are available 
for analyzing data from single-cell RNA-sequencing experiments ​[1]​. For experimental 
researchers and method users, this represents both an opportunity and a challenge, since 
method choice can significantly affect conclusions. 
 
Benchmarking studies are carried out by computational researchers to compare the 
performance of different methods, using reference datasets and a range of evaluation criteria. 
Benchmarks may be performed by authors of new methods to demonstrate performance 
improvements or other advantages; by independent groups interested in systematically 
comparing existing methods; or organized as community challenges. ‘Neutral’ benchmarking 
studies, i.e., those performed independently from new method development by authors without 
any perceived bias, and with a focus on the comparison itself, are especially valuable for the 
research community ​[2,3]​. 
 
From our experience conducting benchmarking studies in computational biology, we have 
learned several key lessons that we aim to synthesize in this review. A number of previous 
reviews have addressed this topic from a range of perspectives, including: overall commentaries 
and recommendations on benchmarking design ​[2,4–9]​; surveys of design practices followed by 
existing benchmarks ​[7]​; the importance of neutral benchmarking studies ​[3]​; principles for the 
design of real-data benchmarking studies ​[10,11]​ and simulation studies ​[12]​; the incorporation 
of meta-analysis techniques into benchmarking ​[13–16]​; the organization and role of community 
challenges ​[17,18]​; and discussions on benchmarking design for specific types of methods 
[19,20]​. More generally, benchmarking may be viewed as a form of meta-research ​[21]​. 
 
Our aim is to complement previous reviews by providing a summary of essential guidelines for 
designing, performing, and interpreting benchmarks. While all guidelines are essential for a truly 
excellent benchmark, some are more fundamental than others. Our target audience consists of 
computational researchers who are interested in performing a benchmarking study, or who have 
already begun one. Our review spans the full ‘pipeline’ of benchmarking, from defining the 
scope to best practices for reproducibility. This includes crucial questions regarding design and 
evaluation principles: e.g., using rankings according to evaluation metrics to identify a set of 
high-performing methods, and then highlighting different strengths and tradeoffs among these. 
 
The review is structured as a series of guidelines (Fig. 1), each explained in detail in the 
following sections. We use examples from computational biology; however, we expect that most 
arguments apply equally to other fields. We hope that these guidelines will continue the 
discussion on benchmarking design, as well as assisting computational researchers to design 
and implement rigorous, informative, and unbiased benchmarking analyses.  
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Fig. 1: Summary of guidelines 
The guidelines in this review can be summarized in the following set of recommendations. 
Each recommendation is discussed in more detail in the corresponding section in the text. 
 
1. Define the purpose and scope of the benchmark. 
2. Include all relevant methods. 
3. Select (or design) representative datasets. 
4. Choose appropriate parameter values and software versions. 
5. Evaluate methods according to key quantitative performance metrics. 
6. Evaluate secondary measures including computational requirements, user- 
friendliness, installation procedures, and documentation quality. 
7. Interpret results and provide recommendations from both user and method developer 
perspectives. 
8. Publish results in an accessible format. 
9. Design the benchmark to enable future extensions. 
10. Follow reproducible research best practices, by making code and data publicly 
available. 
 
 
Defining the purpose and scope 
The purpose and scope of a benchmark should be clearly defined at the beginning of the study, 
and will fundamentally guide the design and implementation. In general, we can define three 
broad types of benchmarking studies: (i) those by method developers, to demonstrate the merits 
of their approach (e.g., ​[22–26]​); (ii) neutral studies performed to systematically compare 
methods for a certain analysis, either conducted directly by an independent group (e.g., ​[27–38]​) 
or in collaboration with method authors (e.g., ​[39]​); or, (iii) those organized in the form of a 
community challenge, such as those from the DREAM ​[40–44]​, FlowCAP ​[45,46]​, CASP ​[47,48]​, 
CAMI ​[49]​, Assemblathon ​[50,51]​, MAQC/SEQC ​[52–54]​, and GA4GH ​[55]​ consortia. 
 
A neutral benchmark or community challenge should be as comprehensive as possible; 
although for any benchmark, there will be tradeoffs in terms of available resources. To minimize 
perceived bias, a research group conducting a neutral benchmark should be approximately 
equally familiar with all included methods, reflecting typical usage of the methods by 
independent researchers ​[3]​. Alternatively, the group could include the original method authors, 
so that each method is evaluated under optimal conditions; methods whose authors decline to 
take part should be reported. In either case, bias due to focusing attention on particular methods 
should be avoided; e.g., when tuning parameters or fixing bugs. Strategies to avoid these types 
of biases, such as the use of blinding, have been previously proposed ​[10]​. 
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By contrast, when introducing a new method, the focus of the benchmark will be on evaluating 
the relative merits of the new method. This may be sufficiently achieved with a less extensive 
benchmark, e.g., by comparing against a smaller set of state-of-the-art and baseline methods. 
However, the benchmark must still be carefully designed to avoid disadvantaging any methods. 
For example, extensively tuning parameters for the new method while using default parameters 
for competing methods would result in a biased representation. Some advantages of a new 
method may fall outside the scope of a benchmark, e.g., a new method may enable more 
flexible analyses than previous methods (e.g., beyond two-group comparisons in differential 
analyses ​[22]​). 
 
Finally, results should be summarized in the context of the original purpose of the benchmark. A 
neutral benchmark or community challenge should provide clear guidelines for method users, 
and highlight weaknesses in current methods so that these can be addressed by method 
developers. On the other hand, benchmarks performed to introduce a new method should 
discuss what the new method offers compared to the current state-of-the-art, such as 
discoveries that would otherwise not be possible. 
 
 
Selection of methods 
The selection of methods to include in the benchmark will be guided by the purpose and scope 
of the study. A neutral benchmark should include all available methods for a certain type of 
analysis. In this case, the publication describing the benchmark will also function as a review of 
the literature; a summary table describing the methods is a key output (e.g., see Fig. 2 in ​[27]​ or 
Table 1 in ​[31]​). Alternatively, it may make sense to include only a subset of methods, by 
defining inclusion criteria: e.g., all methods that: (i) provide freely available software 
implementations; (ii) are available for commonly used operating systems; and, (iii) can 
successfully be installed without errors following a reasonable amount of trouble-shooting. Such 
criteria should be chosen without favoring any methods, and exclusion of any widely used 
methods should be justified. A useful strategy can be to involve method authors within the 
process, since they may provide additional details on optimal usage. In addition, community 
involvement can lead to new collaborations and inspire future method development. However, 
the overall neutrality and balance of the resulting research team should be maintained. Finally, if 
the benchmark is organized as a community challenge, the selection of methods will be 
determined by the participants. In this case, it is important to communicate the initiative widely; 
e.g., through an established network such as DREAM challenges. However, some authors may 
choose not to participate; a summary table documenting non-included methods should be 
provided in this case. 
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When developing a new method, it is generally sufficient to select a representative subset of 
existing methods to compare against. For example, this could consist of the current 
best-performing methods (if known), a simple ‘baseline’ method, and any methods that are 
widely used. The selection of competing methods should ensure an accurate and unbiased 
assessment of the relative merits of the new approach, compared to the current state-of-the-art. 
In fast-moving fields, for a truly excellent benchmark, method developers should be prepared to 
update their benchmarks or design them to easily allow extensions as new methods emerge. 
 
 
Selection (or design) of datasets 
The selection of reference datasets is a critical design choice. If suitable publicly accessible 
datasets cannot be found, they will need to be generated or constructed, either experimentally 
or by simulation. Including a variety of datasets ensures that methods can be evaluated under a 
wide range of conditions. In general, reference datasets can be grouped into two main 
categories: simulated (or synthetic) and real (or experimental). 
 
Simulated data have the advantage that a known true signal (or ‘ground truth’) can easily be 
introduced; e.g., whether a gene is differentially expressed. Quantitative performance metrics 
measuring the ability to recover the known truth can then be calculated. However, it is important 
to demonstrate that simulations accurately reflect relevant properties of real data, by inspecting 
empirical summaries of both simulated and real datasets (e.g., using automated tools ​[56]​). The 
set of empirical summaries to use is context-specific; e.g., for single-cell RNA-sequencing, 
dropout profiles and dispersion-mean relationships should be compared ​[29]​; for DNA 
methylation, correlation patterns among neighboring CpG sites should be investigated ​[57]​; for 
comparing mapping algorithms, error profiles of the sequencing platforms should be considered 
[58]​. Simplified simulations can also be useful, to evaluate a new method under a basic 
scenario, or to systematically test aspects such as scalability and stability. However, overly 
simplistic simulations should be avoided, since these will not provide useful information on 
performance. A further advantage of simulated data is that it is possible to generate as much 
data as required; e.g., to study variability and draw statistically valid conclusions. 
 
Experimental data often do not contain a ground truth, making it difficult to calculate 
performance metrics. Instead, methods may be evaluated by comparing them against each 
other (e.g., overlap between sets of detected differential features ​[23]​), or against a current 
widely accepted method or ‘gold standard’ (e.g., manual gating to define cell populations in 
high-dimensional cytometry ​[31,45]​, or fluorescence in situ hybridization to validate absolute 
copy number predictions ​[6]​). In the context of supervised learning, the response variable to be 
predicted is known in the manually labeled training and test data. However, individual datasets 
should not be over-used, and using the same dataset for both method development and 
evaluation should be avoided, due to the risk of overfitting and overly optimistic results 
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[59,60]​. In some cases, it is also possible to design experimental datasets containing a ground 
truth. Examples include: (i) ‘spiking in’ synthetic RNA molecules at known relative 
concentrations ​[61]​ in RNA-sequencing experiments (e.g., ​[54,62]​); (ii) large-scale validation of 
gene expression measurements by quantitative polymerase chain reaction (e.g., ​[54]​); (iii) using 
genes located on sex chromosomes as a proxy for silencing of DNA methylation status (e.g., 
[26,63]​); (iv) using fluorescence-activated cell sorting to sort cells into known subpopulations 
prior to single-cell RNA-sequencing (e.g., ​[29,64,65]​); or, (v) mixing different cell lines to create 
‘pseudo-cells’ ​[66]​. However, it may be difficult to ensure that the ground truth represents an 
appropriate level of variability; e.g., the variability of spiked-in material, or whether method 
performance on cell line data is relevant to outbred populations. Alternatively, experimental 
datasets may be evaluated qualitatively, for example by judging whether each method can 
recover previous discoveries, although this strategy relies on the validity of previous results. 
 
A further technique is to design ‘semi-simulated’ datasets that combine real experimental data 
with an ‘in silico’ (i.e., computational) spike-in signal, e.g., by combining cells or genes from ‘null’ 
(e.g., healthy) samples with a subset of cells or genes from samples expected to contain a true 
differential signal (examples include ​[22,67,68]​). This strategy can create datasets with more 
realistic levels of variability and correlation, together with a ground truth. 
 
Overall, there is no perfect reference dataset, and the selection of appropriate datasets will 
involve tradeoffs, e.g., regarding the level of complexity. Both simulated and experimental data 
should not be too ‘simple’ (e.g., two of the datasets in the FlowCAP-II challenge ​[45]​ gave 
perfect performance for several algorithms) or too ‘difficult’ (e.g., for the third dataset in 
FlowCAP-II, no algorithms performed well); in these situations, it can be impossible to 
distinguish performance. In some cases, individual datasets have also been found to be 
unrepresentative, leading to over-optimistic or otherwise biased assessment of methods (e.g., 
[69]​). Overall, the key to truly excellent benchmarking is diversity of evaluations, i.e., using a 
range of metrics and datasets that span the range of those that might be encountered in 
practice, so that performance estimates can be credibly extrapolated. 
 
 
Parameters and software versions 
Parameter settings can have a crucial impact on performance. Some methods have a large 
number of parameters, and tuning parameters to optimal values can require significant effort 
and expertise. For a neutral benchmark, a range of parameter values should ideally be 
considered for each method; although tradeoffs need to be considered regarding available time 
and computational resources. Importantly, the selection of parameter values should comply with 
the neutrality principle, i.e., certain methods should not be favored over others through more 
extensive parameter tuning. 
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There are three major strategies for choosing parameters. The first (and simplest) is to use 
default values for all parameters. Default parameters may be adequate for many methods, 
although this is difficult to judge in advance. While this strategy may be viewed as too simplistic 
for some neutral benchmarks, it reflects typical usage. We used default parameters in several 
neutral benchmarks where we were interested in performance for untrained users ​[27,70,71]​. In 
addition, for ​[27]​, due to the large number of methods and datasets, total runtime was already 
around a week using 192 processor cores, necessitating judgment in the scope of parameter 
tuning. The second strategy is to choose parameters based on previous experience, or 
published values. This relies on familiarity with the methods and the literature, reflecting usage 
by expert users. The third strategy is to use a systematic or automated parameter tuning 
procedure; e.g., a ‘grid search’ across ranges of values for multiple parameters, or techniques 
such as cross-validation (e.g., ​[30]​). The strategies may also be combined; e.g., setting 
non-critical parameters to default values, and performing a grid search for key parameters. 
Regardless, neutrality should be maintained: comparing methods with the same strategy makes 
sense, while comparing one method with default parameters against another with extensive 
tuning makes for an unfair comparison. 
 
For benchmarks performed to introduce a new method, comparing against a single set of 
optimal parameter values for competing methods is often sufficient; these values may be 
selected during initial exploratory work, or by consulting documentation. However, as outlined 
above, bias may be introduced by tuning the parameters of the new method more extensively. 
The parameter selection strategy should be transparently discussed during the interpretation of 
the results, to avoid the risk of over-optimistic reporting due to expending more ‘researcher 
degrees of freedom’ on the new method ​[5,72]​. 
 
Software versions can also influence results, especially if updates include major changes to 
methodology (e.g., ​[73]​). Final results should generally be based on the latest available 
versions, which may require re-running some methods if updates become available during the 
course of a benchmark. 
 
 
Evaluation criteria: key quantitative performance metrics 
Evaluation of methods will rely on one or more quantitative performance metrics (Fig. 2a). The 
choice of metric depends on the type of method and data. For example, for classification tasks 
with a ground truth, metrics include the true positive rate (TPR; sensitivity or recall), false 
positive rate (FPR; 1 - specificity), and false discovery rate (FDR). For clustering tasks, common 
metrics include the F1 score, adjusted Rand index, normalized mutual information, precision, 
and recall; some of these can be calculated at the cluster level as well as averaged (and 
optionally weighted) across clusters (e.g., these metrics were used to evaluate clustering 
methods in our own work ​[28,31]​ and by others ​[33,45,74]​). Several of these metrics can also be 
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compared visually to capture the tradeoff between sensitivity and specificity, e.g., using receiver 
operating characteristic (ROC) curves (TPR vs. FPR), TPR vs. FDR curves, or precision-recall 
(PR) curves (Fig. 2b). For imbalanced datasets, PR curves have been shown to be more 
informative than ROC curves ​[75,76]​. These visual metrics can also be summarized as a single 
number, such as area under the ROC or PR curve; examples from our work include ​[22,29]​. In 
addition to the tradeoff between sensitivity and specificity, a method’s ‘operating point’ is 
important; in particular, whether the threshold used (e.g., 5% FDR) is calibrated to achieve the 
specified error rate. We often overlay this onto TPR-FDR curves by filled or open circles (e.g., 
Fig. 2b, generated using the iCOBRA package ​[77]​); examples from our work include 
[22,23,25,78]​. 
 
For methods with continuous-valued output (e.g., effect sizes or abundance estimates), metrics 
include the root mean square error, distance measures, Pearson correlation, sum of absolute 
log-ratios, log-modulus, and cross-entropy. As above, the choice of metric depends on the type 
of method and data (e.g., ​[41,79]​ used correlation, while ​[48]​ used root mean square deviation). 
Further classes of methods include those generating graphs, phylogenetic trees, overlapping 
clusters, or distributions; these require more complex metrics. In some cases, custom metrics 
may need to be developed (e.g., we defined new metrics for topologies of developmental 
trajectories in ​[27]​). When designing custom metrics, it is important to assess their reliability 
across a range of prediction values (e.g., ​[80,81]​). For some metrics, it may also be useful to 
assess uncertainty, e.g., via confidence intervals. In the context of supervised learning, 
classification or prediction accuracy can be evaluated by cross-validation, bootstrapping, or on a 
separate test dataset (e.g., ​[13,46]​). In this case, procedures to split data into training and test 
sets should be appropriate for the data structure and the prediction task at hand (e.g., leaving 
out whole samples or chromosomes ​[82]​). 
 
Additional metrics that do not rely on a ground truth include measures of stability, stochasticity, 
and robustness. These measures may be quantified by running methods multiple times using 
different inputs or subsampled data (e.g., we observed substantial variability in performance for 
some methods in ​[29,31]​). ‘Missing values’ may occur if a method does not return any values for 
a certain metric, e.g., due to a failure to converge or other computational issues such as 
excessive runtime or memory requirements (e.g., ​[27,29,31]​). Fallback solutions such as 
imputation may be considered in this case ​[83]​, although these should be transparently 
reported. For non-deterministic methods (e.g., with random starts or stochastic optimization), 
variability in performance when using different random seeds or subsampled data should be 
characterized. Null comparisons can be constructed by randomizing group labels such that 
datasets do not contain any true signal, which can provide information on error rates (e.g., 
[22,25,26]​). However, these must be designed carefully to avoid confounding by batch or 
population structure, and to avoid strong within-group batch effects that are not accounted for. 
 
For most benchmarks, multiple metrics will be relevant. Focusing on a single metric can give an 
incomplete view: methods may not be directly comparable if they are designed for different 
tasks, and different users may be interested in different aspects of performance. Therefore, a 
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crucial design decision is whether to focus on an overall ranking, e.g., by combining or 
weighting multiple metrics. In general, it is unlikely that a single method will perform best across 
all metrics, and performance differences between top-ranked methods for individual metrics can 
be small. Therefore, a good strategy is to use rankings from multiple metrics to identify a set of 
consistently high-performing methods, and then highlight the different strengths of these 
methods. For example, in ​[31]​, we identified methods that gave good clustering performance, 
and then highlighted differences in runtimes among these. In several studies, we have 
presented results in the form of a graphical summary of performance according to multiple 
criteria (examples include Fig. 3 in ​[27]​ and Fig. 5 in ​[29]​ from our work; and Fig. 2 in ​[39]​ and 
Fig. 6 in ​[32]​ from other authors). Identifying methods that consistently underperform can also 
be useful, to allow readers to avoid these. 
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Fig. 2.​ Summary and examples of performance metrics. (a) Schematic overview of classes of frequently 
used performance metrics, including examples (gray boxes). (b) Examples of popular visualizations of 
quantitative performance metrics for classification methods, using reference datasets with a ground truth: 
(i) ROC curves, (ii) TPR vs. FDR curves (circles represent observed TPR and FDR at typical FDR 
thresholds of 1%, 5%, and 10%; filled circles indicate observed FDR lower than or equal to the imposed 
threshold), and (iii) PR curves. Visualizations in (b) generated using iCOBRA R/Bioconductor 
package ​[77]​. 
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Evaluation criteria: secondary measures 
In addition to the key quantitative performance metrics, methods should also be evaluated 
according to secondary measures including runtime, scalability, and other computational 
requirements, as well as qualitative aspects such as user-friendliness, installation procedures, 
code quality, and documentation quality (Fig. 2a). From the user perspective, the final choice of 
method may involve tradeoffs according to these measures: an adequately performing method 
may be preferable to a top-performing method that is especially difficult to use. 
 
In our experience, runtimes and scalability can vary enormously between methods (e.g., in our 
work, runtimes for cytometry clustering algorithms ​[31]​ and metagenome analysis tools ​[79] 
ranged across multiple orders of magnitude for the same datasets). Similarly, memory and other 
computational requirements can vary widely. Runtimes and scalability may be investigated 
systematically, e.g., by varying the number of cells or genes in a single-cell RNA-sequencing 
dataset ​[28,29]​. In many cases, there is a tradeoff between performance and computational 
requirements. In practice, if computational requirements for a top-performing method are 
prohibitive, then a different method may be preferred by some users. 
 
User-friendliness, installation procedures, and documentation quality can also be highly variable 
[84,85]​. Streamlined installation procedures can be ensured by distributing the method via 
standard package repositories, such as CRAN and Bioconductor for R, or PyPI for Python. 
Alternative options include GitHub and other code repositories or institutional websites; 
however, these options do not provide users with the same guarantees regarding reliability and 
documentation quality. Availability across multiple operating systems and within popular 
programming languages for data analysis are also important. Availability of graphical user 
interfaces can further extend accessibility, although graphical-only methods hinder 
reproducibility and are thus difficult to include in a systematic benchmark. 
 
For many users, freely available and open source software will be preferred, since it is more 
broadly accessible and can be adapted by experienced users. From the developer perspective, 
code quality and use of software development best practices, such as unit testing and 
continuous integration, are also important. Similarly, adherence to commonly used data formats 
(e.g., GFF/GTF files for genomic features, BAM/SAM files for sequence alignment data, or FCS 
files for flow or mass cytometry data) greatly improves accessibility and extensibility. 
 
High-quality documentation is critical, including help pages and tutorials. Ideally, all code 
examples in the documentation should be continually tested; e.g., as Bioconductor does, or 
through continuous integration. 
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Interpretation, guidelines, and recommendations 
For a truly excellent benchmark, results must be clearly interpreted from the perspective of the 
intended audience. For method users, results should be summarized in the form of 
recommendations. An overall ranking of methods (or separate rankings for multiple evaluation 
criteria) can provide a useful overview. However, as mentioned above, some methods may not 
be directly comparable (e.g., since they are designed for different tasks), and different users 
may be interested in different aspects of performance. In addition, it is unlikely that there will be 
a clear ‘winner’ across all criteria, and performance differences between top-ranked methods 
can be small. Therefore, an informative strategy is to use the rankings to identify a set of 
high-performing methods, and to highlight the different strengths and tradeoffs among these 
methods. The interpretation may also involve biological or other domain knowledge to establish 
the scientific relevance of differences in performance. Importantly, neutrality principles should 
be preserved during the interpretation. 
 
For method developers, the conclusions may include guidelines for possible future development 
of methods. By assisting method developers to focus their research efforts, high-quality 
benchmarks can have significant impact on the progress of methodological research. 
 
Limitations of the benchmark should be transparently discussed. For example, in ​[27]​ we used 
default parameters for all methods, while in ​[31]​ our datasets relied on manually gated reference 
cell populations as the ground truth. Without a thorough discussion of limitations, a benchmark 
runs the risk of misleading readers; in extreme cases, this may even harm the broader research 
field by guiding research efforts in the wrong directions. 
 
 
Publication and reporting of results 
The publication and reporting strategy should emphasize clarity and accessibility. Visualizations 
summarizing multiple performance metrics can be highly informative for method users 
(examples include Fig. 3 in ​[27]​ and Fig. 5 in ​[29]​ from our own work; as well as Fig. 6 in ​[32]​). 
Summary tables are also useful as a reference (e.g., ​[31,45]​). Additional visualizations, such as 
flow charts to guide the choice of method for different analyses, are a helpful way to engage the 
reader (e.g., Fig. 5 in ​[27]​). 
 
For extensive benchmarks, online resources enable readers to interactively explore the results 
(examples from our work include ​[27,29]​, which allow users to filter metrics and datasets). Fig. 3 
displays an example of an interactive website from one of our benchmarks ​[27]​, which facilitates 
exploration of results and assists users with choosing a suitable method. While tradeoffs should 
12 
be considered in terms of the amount of work required, these efforts are likely to have significant 
benefit for the community. 
 
In most cases, results will be published in a peer-reviewed article. For a neutral benchmark, the 
benchmark will be the main focus of the paper. For a benchmark to introduce a new method, the 
results will form one part of the exposition. We highly recommend publishing a preprint prior to 
peer review (e.g., on bioRxiv or arXiv) to speed up distribution of results, broaden accessibility, 
and solicit additional feedback. In particular, direct consultation with method authors can 
generate highly useful feedback (examples from our work are described in the 
acknowledgments in ​[79,86]​). Finally, at publication time, considering open access options will 
further broaden accessibility. 
 
 
 
 
Fig. 3.​ Example of an interactive website allowing users to explore the results of one of our benchmarking 
studies ​[27]​. This website was created using the Shiny framework in R. 
 
 
Enabling future extensions 
Since new methods are continually emerging ​[1]​, benchmarks can quickly become out of date. 
To avoid this, a truly excellent benchmark should be extensible. For example, creating public 
repositories containing code and data allows other researchers to build on the results to include 
new methods or datasets, or to try different parameter settings or pre-processing procedures 
(examples from our work include ​[27–31]​). In addition to raw data and code, it is useful to 
distribute pre-processed and/or results data (examples include ​[28,29,77]​ from our work and 
[74,87,88]​ from others), especially for computationally intensive benchmarks. This may be 
combined with an interactive website, where users can upload results from a new method, to be 
included in an updated comparison either automatically or by the original authors (e.g., 
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[35,89,90]​). ‘Continuous’ benchmarks, which are continually updated, are especially convenient 
(e.g., ​[91]​), but may require significant additional effort. 
 
 
Reproducible research best practices 
Reproducibility of research findings has become an increasing concern in numerous areas of 
study ​[92]​. In computational sciences, reproducibility of code and data analyses has been 
recognized as a useful ‘minimum standard’ that enables other researchers to verify analyses 
[93]​. Access to code and data have previously enabled method developers to uncover potential 
errors in published benchmarks due to suboptimal usage of methods ​[73,94,95]​. Journal 
publication policies can play a crucial role in encouraging authors to follow these practices ​[96]​; 
experience shows that statements that code and data are ‘available on request’ are often 
insufficient ​[97]​. In the context of benchmarking, code and data availability also provides further 
benefits: for method users, code repositories serve as a source of annotated code to run 
methods and build analysis pipelines, while for developers, code repositories can act as a 
prototype for future method development work. 
 
Parameter values (including random seeds) and software versions should be clearly reported, to 
ensure complete reproducibility. For methods that are run using scripts, these will be recorded 
within the scripts. In R, the command ‘sessionInfo()’ gives a complete summary of package 
versions, the version of R, and the operating system. For methods only available via graphical 
interfaces, parameters and versions must be recorded manually. Reproducible workflow 
frameworks, such as the Galaxy platform ​[98]​, can also be helpful. A summary table or 
spreadsheet of parameter values and software versions can be published as supplementary 
information along with the publication describing the benchmark (e.g., Supporting Information 
Table S1 in our study ​[31]​). 
 
Automated workflow management tools and specialized tools for organizing benchmarks 
provide sophisticated options for setting up benchmarks and creating a reproducible record, 
including software environments, package versions, and parameter values. Examples include 
SummarizedBenchmark ​[99]​, DataPackageR ​[100]​, workflowr ​[101]​, and Dynamic Statistical 
Comparisons ​[102]​. Some tools (e.g., workflowr) also provide streamlined options for publishing 
results online. In machine learning, OpenML provides a platform to organize and share 
benchmarks ​[103]​. More general tools for managing computational workflows, including 
Snakemake ​[104]​, Make, Bioconda ​[105]​, and conda, can be customized to capture setup 
information. Containerization tools such as Docker and Singularity may be used to encapsulate 
a software environment for each method, preserving the package version as well as 
dependency packages and the operating system, and facilitating distribution of methods to end 
users (e.g., in our study ​[27]​). Best practices from software development are also useful, 
including unit testing and continuous integration. 
14 
 
Many free online resources are available for sharing code and data, including GitHub and 
Bitbucket, repositories for specific data types (e.g., ArrayExpress ​[106]​, the Gene Expression 
Omnibus ​[107]​, and FlowRepository ​[108]​), and more general data repositories (e.g., figshare, 
Dryad, Zenodo, Bioconductor ExperimentHub, and Mendeley Data). Customized resources 
(examples from our work include ​[29,77]​) can be designed when additional flexibility is needed. 
Several repositories allow the creation of ‘digital object identifiers’ (DOIs) for code or data 
objects. In general, preference should be given to publicly funded repositories, which provide 
greater guarantees for long-term archival stability ​[84,85]​. 
 
An extensive literature exists on best practices for reproducible computational research (e.g., 
[109]​). Some practices (e.g., containerization) may involve significant additional work; however, 
in our experience, almost all efforts in this area prove useful, especially by facilitating later 
extensions by ourselves or other researchers. 
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Principle 
(see Fig. 1) 
How 
essential? 
Tradeoffs Potential pitfalls 
1. Defining the 
purpose and scope 
✶✶✶ How comprehensive 
the benchmark should 
be 
- Scope too broad: too much work given available 
resources 
- Scope too narrow: unrepresentative and possibly 
misleading results 
2. Selection of 
methods 
✶✶✶ Number of methods to 
include 
- Excluding key methods 
3. Selection (or 
design) of datasets 
✶✶✶ Number and types of 
datasets to include 
- Subjectivity in the choice of datasets: e.g., 
selecting datasets that are unrepresentative of 
real-world applications 
- Too few datasets or simulation scenarios 
- Overly simplistic simulations 
4. Parameter and 
software versions 
✶✶ Amount of parameter 
tuning 
- Extensive parameter tuning for some methods 
while using default parameters for others (e.g., 
competing methods) 
5. Evaluation criteria: 
key quantitative 
performance metrics 
✶✶✶ Number and types of 
performance metrics 
- Subjectivity in the choice of metrics: e.g., 
selecting metrics that do not translate to 
real-world performance 
- Metrics that give over-optimistic estimates of 
performance 
- Methods may not be directly comparable 
according to individual metrics (e.g., if methods 
are designed for different tasks) 
6. Evaluation criteria: 
secondary measures 
✶✶ Number and types of 
performance metrics 
- Subjectivity of qualitative measures such as 
user-friendliness, installation procedures, and 
documentation quality 
- Subjectivity in relative weighting between 
multiple metrics 
- Measures such as runtime and scalability 
depend on processor speed and memory 
7. Interpretation, 
guidelines, and 
recommendations 
✶✶ Generality vs. 
specificity of 
recommendations 
- Performance differences between top-ranked 
methods may be minor 
- Different readers may be interested in different 
aspects of performance 
8. Publication and 
reporting of results 
✶ Amount of resources 
to dedicate to building 
online resources 
- Online resources may not be accessible (or may 
no longer run) several years later 
9. Enabling future 
extensions 
✶✶ Amount of resources 
to dedicate to 
ensuring extensibility 
- Selection of methods or datasets for future 
extensions may be unrepresentative (e.g., due to 
requests from method authors) 
10. Reproducible 
research best 
practices 
✶✶ Amount of resources 
to dedicate to 
reproducibility 
- Some tools may not be compatible or accessible 
several years later 
Table 1.​ Summary of our views regarding ‘how essential’ each principle is for a truly excellent benchmark 
(higher number of stars means more central to the evaluation); along with examples of key tradeoffs and 
potential pitfalls relating to each principle. 
  
16 
Discussion 
In this review, we have described a set of key principles for designing a high-quality 
computational benchmark. In our view, elements of all of these principles are essential. 
However, we have also emphasized that any benchmark will involve tradeoffs, due to limited 
expertise and resources, and that some principles are less central to the evaluation. Table 1 
provides a summary of examples of key tradeoffs and pitfalls related to benchmarking, along 
with our judgment of how truly ‘essential’ each principle is. 
 
There are a number of potential pitfalls that may arise from benchmarking studies (Table 1). For 
example, subjectivity in the choice of datasets or evaluation metrics could bias the results. In 
particular, a benchmark that relies on unrepresentative data or metrics that do not translate to 
real-world scenarios may be misleading by showing poor performance for methods that 
otherwise perform well. This could harm method users, who may select an inappropriate method 
for their analyses, as well as method developers, who may be discouraged from pursuing 
promising methodological approaches. In extreme cases, this could negatively affect the 
research field by influencing the direction of research efforts. A thorough discussion of the 
limitations of a benchmark can help avoid these issues. Over the longer term, critical 
evaluations of published benchmarks, so-called meta-benchmarks, will also be informative 
[10,13,14]​. 
 
Well-designed benchmarking studies provide highly valuable information for users and 
developers of computational methods, but require careful consideration of a number of 
important design principles. In this review, we have discussed a series of guidelines for rigorous 
benchmarking design and implementation, based on our experiences in computational biology. 
We hope these guidelines will assist computational researchers to design high-quality, 
informative benchmarks, which will contribute to scientific advances through informed selection 
of methods by users and targeting of research efforts by developers. 
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